The Marengo Asia-Werfen partnership will play a crucial role in the development of ‘Centre of Excellence’
A very first-of-its-kind in the entire India and South Asia region, Marengo Asia Hospitals brings one of the most advanced techniques of transfusion-free heart transplants. An agreement was signed by Dr Raajiv Singhal, MD and Group CEO, Marengo Asia Hospitals and Anurag Mishra, Regional Director- India and South Asia, Werfen.
Other members to join Dr Singhal were Dr Keyur Parikh, Chairman – Marengo CIMS Hospital, Dr Dhiren Shah, Director – Heart & Lung Transplant Program, and Dr Ajay Gandhi, Associate Director- Clinical Affairs, Werfen India. Dr Klaus Goerlinger, consultant for anaesthesiology, emergency and intensive care medicine and globally renowned for haemostaseology, will be leading the programme for implementation of the protocols. Dr Goerlinger was associated with the University Essen hospital, Germany for around three decades. He is currently the global Medical director – PBM for Werfen.
Marengo Asia Healthcare group, in a strategic partnership with Werfen, is poised to adopt Goal Directed Bleeding Management (GDBM) solutions, reducing complications for patients. Marengo Asia Healthcare group of hospitals will also adopt the unique and innovative solution ‘GEMWeb Live’, a real-time onscreen dashboard of diagnostic assays and graphs for cardiac surgical procedures. Our flagship hospital, Marengo CIMS Hospital, Ahmedabad will become the first Indian corporate hospital to be equipped with such a feature. With the patient’s safety and better outcomes as our core objective and the admixture of clinical competence and optimal usage of diagnostic and management-guiding devices in the evaluation of coagulopathic bleeding.
The Marengo Asia-Werfen partnership will play a crucial role in the development of ‘Centre of Excellence.’ MCIMS adopts, at the essence of its heart transplant and cardiothoracic vascular surgical segment, GDBM through state-of-art health technology and protocol-driven clinical practices and we will be the first institution in South Asia to do so.
Dr Singhal says, “With 38 heart transplants conducted, we are taking this higher to as a centre of excellence for transfusion-free heart transplants. With recognition as a preferred destination for our clinical excellence in heart transplants, we are committed to bringing optimized treatment solutions to our patients with a focus on ‘Patient First’. Through a strategic collaboration with Werfen, we will pioneer in bringing transfusion-free heart transplants for the first time in the India and South Asia region. This will enhance the optimised clinical outcomes and bring a new definition to patient experience and service deliveries. We hope that this will be a game changer in creating benchmarks in the healthcare industry.”
Dr Shah says, “In heart transplant surgeries, allogenic blood transfusions are the norm. With this unique technique, we are poised at changing the paradigms of heart transplant techniques in blood transfusion. We are sharing knowledge and expertise on strategies that are aligned with transfusion-free procedures. Appropriate use of medical strategies to reduce transfusions, minimise blood loss, increase safety for the patient, incidence and severity of complications, and reduced mortality related to allogenic blood transfusions are beneficial to patients. The blood of a patient with the same DNA has several benefits. Using a patient’s blood cuts infection rates by more than half. This knowledge-sharing platform enables us to bring safer techniques, almost negligible blood transfusions and faster recovery for the transplant patients.”
Dr Parikh says, “Marengo CIMS Hospital is recognised for the very first heart transplant conducted in the state of Gujarat. With this collaboration, we are initiating a technique that will serve as a landmark in the healthcare industry. We hope to set higher benchmarks in the scope of heart transplants in India by leading this technique that will benefit the patients much more.”
Anurag Kumar Mishra, Regional Director- India and South Asia, Werfen, says, “The futuristic partnership agreement signed between Marengo Asia Healthcare and Werfen is one of its kind in South Asia, and it ensures implementation of Patient Blood Management solutions across all the healthcare establishments of Marengo Asia, thus facilitating faster and more accurate clinical decision-making and improving patients’ outcomes. At Werfen, our core purpose of ‘Powering Patient Care’ lies at the heart of everything we do and with this partnership, we are committed to empowering the healthcare facilities of Marengo Asia group of hospitals with our innovative technology and global clinical expertise.”
Dr Gandhi says, “Patient Blood Management is a compelling need for the healthcare ecosystem, particularly in the developing economies, where anaemia is common, and blood continues to remain a scarce resource. The clinical and administrative leadership of CIMS has displayed their commitment to ensuring the adoption of WHO-recommended best practices towards patient safety in the settings of peri-operative bleeding. Werfen India and its Clinical team are committed to complementing and enhancing their knowledge and skill set to accomplish Goal Directed Bleeding Management protocols across all the establishments of Marengo Asia group.”
